Home › Funds › Two Sigma Investments › PCVX
Two Sigma Investments position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)273.88K sh
Reported value held$15.92M
Portfolio Weight0.01%
First reportedQ4 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 200.16K | $9.60M | New |
| Q1 2023 | 238.40K | $8.94M | Add |
| Q2 2025 | 87.56K | $2.85M | New |
| Q3 2025 | 107.59K | $3.88M | Add |
| Q4 2025 | 111.31K | $5.14M | Add |
| Q1 2026 | 111.31K | $6.47M | Hold |
| Q2 2026 | 273.88K | $15.92M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026